stockrowClover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) EBITDA
Clover Health Investments, Corp.'s EBITDA for fiscal 2025 was −$85.7M, compared with −$46.9M in fiscal 2024. Over the twelve months to 30 September 2026 it was $12.7M. Over the past ten years it has ranged from −$621.8M (fiscal 2021) to −$46.9M (fiscal 2024); the current reading is higher than 71% of that period. Clover Health Investments, Corp. ranks 11th of 12 Healthcare Plans companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | −$85.7M | — |
| FY2024 | −$46.9M | — |
| FY2023 | −$206.8M | — |
| FY2022 | −$287.0M | — |
| FY2021 | −$621.8M | — |
| FY2020 | −$71.2M | — |
| FY2019 | −$169.6M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $6.6M | (76.54%) |
| Jun 2026 | $28.1M | 2.66% |
| Mar 2026 | $27.4M | — |
| Dec 2025 | −$49.4M | — |
| 23 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| CI Cigna Group compare | $12.7B |
| ELV Elevance Health, Inc. compare | $9.2B |
| HUM Humana Inc. compare | $3.1B |
| CNC Centene Corporation compare | $2.2B |
| OSCR Oscar Health, Inc. compare | $632.0M |
| MOH Molina Healthcare, Inc compare | $333.0M |
| PGNY Progyny, Inc. compare | $117.9M |
| ALHC Alignment Healthcare, Inc. compare | $76.7M |
| CLOV Clover Health Investments, Corp. | $12.7M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on CLOV
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement